Involvement of IL1 and Oncostatin M in Acanthosis

  • Slides: 9
Download presentation
Involvement of IL-1 and Oncostatin M in Acanthosis Associated With Hypertensive Leg Ulcer Jean-Philippe

Involvement of IL-1 and Oncostatin M in Acanthosis Associated With Hypertensive Leg Ulcer Jean-Philippe Giot, Isabelle Paris, Pierre Levillain, Vincent Huguier, Sandrine Charreau, Adrianna Delwail, Martine Garcia, Julien Garnier, François-Xavier Bernard, Guy Dagregorio, Gérard Guillet, Franck Morel, Jean-Claude Lecron, Laure Favot The American Journal of Pathology Volume 182 Issue 3 Pages 806 -818 (March 2013) DOI: 10. 1016/j. ajpath. 2012. 11. 030 Copyright © 2013 American Society for Investigative Pathology Terms and Conditions

Figure 1 The American Journal of Pathology 2013 182806 -818 DOI: (10. 1016/j. ajpath.

Figure 1 The American Journal of Pathology 2013 182806 -818 DOI: (10. 1016/j. ajpath. 2012. 11. 030) Copyright © 2013 American Society for Investigative Pathology Terms and Conditions

Figure 2 The American Journal of Pathology 2013 182806 -818 DOI: (10. 1016/j. ajpath.

Figure 2 The American Journal of Pathology 2013 182806 -818 DOI: (10. 1016/j. ajpath. 2012. 11. 030) Copyright © 2013 American Society for Investigative Pathology Terms and Conditions

Figure 3 The American Journal of Pathology 2013 182806 -818 DOI: (10. 1016/j. ajpath.

Figure 3 The American Journal of Pathology 2013 182806 -818 DOI: (10. 1016/j. ajpath. 2012. 11. 030) Copyright © 2013 American Society for Investigative Pathology Terms and Conditions

Figure 4 The American Journal of Pathology 2013 182806 -818 DOI: (10. 1016/j. ajpath.

Figure 4 The American Journal of Pathology 2013 182806 -818 DOI: (10. 1016/j. ajpath. 2012. 11. 030) Copyright © 2013 American Society for Investigative Pathology Terms and Conditions

Figure 5 The American Journal of Pathology 2013 182806 -818 DOI: (10. 1016/j. ajpath.

Figure 5 The American Journal of Pathology 2013 182806 -818 DOI: (10. 1016/j. ajpath. 2012. 11. 030) Copyright © 2013 American Society for Investigative Pathology Terms and Conditions

Figure 6 The American Journal of Pathology 2013 182806 -818 DOI: (10. 1016/j. ajpath.

Figure 6 The American Journal of Pathology 2013 182806 -818 DOI: (10. 1016/j. ajpath. 2012. 11. 030) Copyright © 2013 American Society for Investigative Pathology Terms and Conditions

Figure 7 The American Journal of Pathology 2013 182806 -818 DOI: (10. 1016/j. ajpath.

Figure 7 The American Journal of Pathology 2013 182806 -818 DOI: (10. 1016/j. ajpath. 2012. 11. 030) Copyright © 2013 American Society for Investigative Pathology Terms and Conditions

Figure 8 The American Journal of Pathology 2013 182806 -818 DOI: (10. 1016/j. ajpath.

Figure 8 The American Journal of Pathology 2013 182806 -818 DOI: (10. 1016/j. ajpath. 2012. 11. 030) Copyright © 2013 American Society for Investigative Pathology Terms and Conditions

Acanthosis nigricans rvar Gunnarsson lknanemi Skilgreining Acanthosis HyperplasiaAcanthosis nigricans rvar Gunnarsson lknanemi Skilgreining Acanthosis Hyperplasia
1 4 1 IL1 IL1 ra IL2 Il41 4 1 IL1 IL1 ra IL2 Il4
Oncostatin M Is a Major Mediator of CardiomyocyteOncostatin M Is a Major Mediator of Cardiomyocyte
Identification of Oncostatin M as a STAT 5Identification of Oncostatin M as a STAT 5
Oncostatin M Is a Growth Factor for EwingOncostatin M Is a Growth Factor for Ewing
TNF and IL1 inhibit through different pathways IFNTNF and IL1 inhibit through different pathways IFN
IL1 and Caspase1 Drive Autoinflammatory Disease Independently ofIL1 and Caspase1 Drive Autoinflammatory Disease Independently of
IL1 and IL10 polymorphisms among Iranian Systemic SclerosisIL1 and IL10 polymorphisms among Iranian Systemic Sclerosis